For the quarter ended March 2024, Teladoc (TDOC) reported income of $646.13 million, up 2.7% over the identical interval final yr. EPS got here in at -$0.49, in comparison with -$0.37 within the year-ago quarter.
The reported income compares to the Zacks Consensus Estimate of $636.98 million, representing a shock of +1.44%. The corporate delivered an EPS shock of -4.26%, with the consensus EPS estimate being -$0.47.
Whereas buyers carefully watch year-over-year adjustments in headline numbers — income and earnings — and the way they examine to Wall Avenue expectations to find out their subsequent plan of action, some key metrics all the time present a greater perception into an organization’s underlying efficiency.
Since these metrics play an important position in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher venture a inventory’s value efficiency.
Right here is how Teladoc carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Avenue analysts:
- U.S. Built-in Care Members: 91.8 million versus the five-analyst common estimate of 89.85 million.
- BetterHelp Paying Customers: 0.42 million versus 0.43 million estimated by 5 analysts on common.
- Continual Care Program Enrollment: 1.12 million in comparison with the 1.13 million common estimate based mostly on 4 analysts.
- Common Income Per U.S. Built-in Care Member: $1.38 in comparison with the $1.38 common estimate based mostly on 4 analysts.
- Visits: 4,600,000 in comparison with the 5,056,574 common estimate based mostly on two analysts.
- Revenues by Phase- Teladoc Well being Built-in Care: $377.11 million versus the seven-analyst common estimate of $370.07 million.
- Revenues by Phase- BetterHelp: $269.02 million in comparison with the $267.37 million common estimate based mostly on seven analysts.
- Revenues by Phase- BetterHelp- Different Wellness Providers: $5.31 million versus the three-analyst common estimate of $4.46 million.
- Revenues by Phase- BetterHelp- Remedy Providers: $263.71 million in comparison with the $261.88 million common estimate based mostly on three analysts.
- Income by Kind- Different: $88.96 million versus $82.25 million estimated by two analysts on common.
- Income by Kind- Entry charges: $557.17 million in comparison with the $555.17 million common estimate based mostly on two analysts.
- Adjusted EBITDA- BetterHelp: $15.47 million versus $15.44 million estimated by 4 analysts on common.
View all Key Company Metrics for Teladoc here>>>
Shares of Teladoc have returned -10.1% over the previous month versus the Zacks S&P 500 composite’s -3% change. The inventory at the moment has a Zacks Rank #3 (Maintain), indicating that it may carry out according to the broader market within the close to time period.
Free – 5 Dividend Shares to Fund Your Retirement
Zacks Funding Analysis has launched a Particular Report that can assist you put together for retirement with 5 various shares that pay whopping dividends. They reduce throughout property administration, upscale shops, monetary establishments, and a few sturdy power producers.
5 Dividend Shares to Embody in Your Retirement Technique is filled with unconventional knowledge and insights you received’t get out of your neighborhood monetary planner.
Download Now – Today It’s FREE >>
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
